Advertisement
MET vs PRI
Which Stock Would AI Choose? MetLife (MET) vs. Primerica (PRI) Stock Comparison
Key Takeaways
- Different scale and focus: MET is a global insurance and asset-management giant, while PRI is a North America-focused term life insurer and financial-products distributor serving middle-income households.
- Diverging growth engines: MetLife is benefiting from broad underwriting strength and international volume growth, while Primerica's momentum is concentrated in its Investment and Savings Products (ISP) segment.
- Contrasting challenges: Primerica is working through soft term life policy sales and elevated lapse rates, whereas MetLife's headwinds are more tied to investment spreads and expense dynamics.
- Relative performance: Both stocks have posted double-digit year-to-date gains, with MetLife trading near record territory on a roughly 22% advance and Primerica up in the mid-teens.
- Valuation profiles differ materially: MetLife trades at a premium earnings multiple relative to the broader insurance industry, reflecting its global diversification and execution momentum.
Introduction
MetLife, Inc. and Primerica, Inc. both operate in the insurance and financial-services arena, yet they represent very different business models, customer bases, and growth profiles. This stock comparison is relevant for investors weighing a diversified global life insurer against a capital-light distribution company anchored in the U.S. middle-market. Understanding how MET and PRI diverge in terms of market positioning, earnings drivers, and risk exposure can help clarify where each may fit in a portfolio under current market conditions.
MET Overview and Recent Performance
MET, or MetLife, is a global provider of insurance, annuities, employee benefits, and asset-management services, operating across the U.S., Asia, Latin America, and EMEA (Europe, the Middle East, and Africa). Recent market activity has been marked by strong execution under its "New Frontier" strategy. In its latest reported quarters, adjusted earnings per share rose roughly 20% year over year, supported by favorable underwriting in Group Benefits, double-digit volume growth in Asia and EMEA, and higher variable investment income. Adjusted return on equity (ROE), a measure of profitability relative to shareholder capital, reached the top of management's target range, while the direct expense ratio improved ahead of plan. This momentum has lifted the shares to near record levels, and analysts have generally raised price targets in response, even as the stock's earnings multiple now sits above the broader insurance peer group.
PRI Overview and Recent Performance
PRI, or Primerica, is a diversified financial-services distribution company that sells term life insurance and third-party investment products, including mutual funds, managed accounts, and annuities, primarily to middle-income families in the United States and Canada. Recent quarters have shown a two-speed story: its Investment and Savings Products segment has delivered record sales and rising client asset values, while term life policy issuance has softened amid cost-of-living pressures on younger households. Adjusted operating earnings per share climbed nearly 20% year over year in the most recent quarter, and the company has continued returning capital through share repurchases and a higher dividend. Relative performance has been solid, with the stock up in the mid-teens on a year-to-date basis, though its term life distribution network has not yet fully recovered to historical productivity levels.
Trending AI Robots
For traders looking to systematize this kind of stock comparison, Tickeron's Trending AI Robots page offers a curated view of its AI trading bots. Tickeron hosts hundreds of AI Trading Bots that monitor thousands of different tickers, but only the strongest performers suited to current market conditions earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance statistics, and the specific set of tickers they trade, giving users a range of approaches to evaluate. Browsing the Trending AI Robots list can help you see which automated strategies are currently positioned in names like MET and PRI and how their signals align with observable market trends.
Head-to-Head Comparison
The clearest contrast between MET and PRI lies in business model and revenue mix. MetLife earns income across underwriting margins, investment spreads, and fee-based asset management in multiple regions, giving it geographic diversification but also exposure to interest-rate and currency dynamics. Primerica relies on a capital-light, fee-oriented distribution model: it cedes much of its mortality risk through reinsurance, so its term life business behaves more like a fee stream, while its ISP segment is sensitive to equity-market levels and client flows.
Growth drivers also diverge. MetLife's recent strength stems from favorable mortality trends, international sales, and disciplined expense management. Primerica's growth is investment-led, powered by record ISP sales and rising client assets that offset a decline in new term life policies. On risk, MetLife faces spread compression in Retirement and Income Solutions and a richer valuation, while Primerica contends with elevated lapse rates, a smaller life-licensed sales force, and market volatility that could pressure fee-based revenue. Market sentiment has favored both, but for different reasons: MetLife is seen as a well-executed global franchise, while Primerica is viewed as a resilient middle-market distribution play with a recovering life business.
Tickeron AI Verdict
Based on trend consistency, stability, and relative positioning, Tickeron's AI would likely lean toward MET in the current environment. MetLife's combination of broad-based earnings growth across segments, strong underwriting results, and sustained price momentum near record highs suggests a more consistent and diversified trend profile. Primerica's investment-led growth is compelling, but its softer term life issuance and distribution productivity introduce more near-term variability. That said, the assessment is probabilistic rather than definitive: Primerica's fee-heavy model and strong capital returns could narrow the gap if term life stabilizes and markets remain supportive, making the relative positioning worth monitoring as new data emerges.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a Buy and PRI is a StrongBuy.
MET in +2.36% Uptrend, advancing for three consecutive days on October 22, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.366) is slightly higher than the industry average of (1.347). P/E Ratio (19.426) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.046) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Momentum Indicator for PRI turns positive, indicating new upward trend
PRI saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 62 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PRI's RSI Oscillator exited the oversold zone, 12 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for PRI just turned positive on October 06, 2026. Looking at past instances where PRI's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.
Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRI advanced for three days, in 209 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
PRI broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PRI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. PRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PRI's P/B Ratio (3.472) is very high in comparison to the industry average of (1.347). P/E Ratio (11.422) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.540) is also within normal values, averaging (0.463). Dividend Yield (0.017) settles around the average of (0.046) among similar stocks. PRI's P/S Ratio (2.710) is slightly higher than the industry average of (1.303).
MET | PRI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 19 | 15 | |
SMR RATING 1..100 | 99 | 33 | |
PRICE GROWTH RATING 1..100 | 15 | 55 | |
P/E GROWTH RATING 1..100 | 11 | 53 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (55) in the Life Or Health Insurance industry is in the same range as PRI (74). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
PRI's Profit vs Risk Rating (15) in the Life Or Health Insurance industry is in the same range as MET (19). This means that PRI’s stock grew similarly to MET’s over the last 12 months.
PRI's SMR Rating (33) in the Life Or Health Insurance industry is significantly better than the same rating for MET (99). This means that PRI’s stock grew significantly faster than MET’s over the last 12 months.
MET's Price Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for PRI (55). This means that MET’s stock grew somewhat faster than PRI’s over the last 12 months.
MET's P/E Growth Rating (11) in the Life Or Health Insurance industry is somewhat better than the same rating for PRI (53). This means that MET’s stock grew somewhat faster than PRI’s over the last 12 months.
| MET | PRI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 55% | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 54% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 55% | 1 day ago 61% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 61% |
| Advances ODDS (%) | 1 day ago 65% | 7 days ago 61% |
| Declines ODDS (%) | 23 days ago 52% | 29 days ago 52% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 48% |
| Aroon ODDS (%) | 1 day ago 47% | 1 day ago 48% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while PRI’s FA Score has 2 green FA rating(s).
- MET’s FA Score: 3 green, 2 red.
- PRI’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 5 TA indicator(s) are bullish while PRI’s TA Score has 4 bullish TA indicator(s).
- MET’s TA Score: 5 bullish, 5 bearish.
- PRI’s TA Score: 4 bullish, 4 bearish.
Price Growth
MET (@Life/Health Insurance) experienced а +3.29% price change this week, while PRI (@Life/Health Insurance) price change was +1.62% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.54%. For the same industry, the average monthly price growth was -0.35%, and the average quarterly price growth was -1.67%.
Reported Earning Dates
MET is expected to report earnings on Nov 04, 2026.
PRI is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (+3.54% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
PRI and
Correlation & Price change
A.I.dvisor indicates that over the last year, PRI has been loosely correlated with MET. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRI jumps, then MET could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBDZ | 25.04 | 0.22 | +0.89% |
| iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) | |||
| FPAS | 24.14 | 0.18 | +0.76% |
| FPA Short Duration Government ETF (FPAS) | |||
| USHY | 35.58 | 0.03 | +0.08% |
| iShares Broad USD High Yield Corporate Bond ETF (USHY) | |||
| STXD | 39.68 | -0.12 | -0.30% |
| Strive 1000 Dividend Growth ETF (STXD) | |||
| INTL | 29.36 | -0.51 | -1.70% |
| Main International ETF (INTL) | |||